S
Simon van der Schans
Researcher at University Medical Center Groningen
Publications - 10
Citations - 40
Simon van der Schans is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Medicine & Outbreak. The author has an hindex of 1, co-authored 3 publications receiving 26 citations. Previous affiliations of Simon van der Schans include University of Groningen.
Papers
More filters
Journal ArticleDOI
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations
Simon van der Schans,Lucas M A Goossens,Melinde Boland,Janwillem W. H. Kocks,Maarten J. Postma,Job F M van Boven,Maureen P.M.H. Rutten-van Mölken +6 more
TL;DR: The majority of studies showed that pharmacologic COPD maintenance treatment is cost effective, but most studies poorly represented the cost effectiveness of real-life medication use.
Journal ArticleDOI
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands.
Rimma Velikanova,Simon van der Schans,Matthias Bischof,R. W. Van Olden,Maarten J. Postma,Cornelis Boersma +5 more
TL;DR: In this article , a cost-utility model was developed to estimate lifetime health effects and costs of NBS for SMA and subsequent treatment versus a treatment pathway without NBS (i.e., diagnosis and treatment after presentation with overt symptoms).
Journal ArticleDOI
The impact of patent expiry on drug prices: insights from the Dutch market.
Simon van der Schans,Gert T Vondeling,Qi Cao,Simon van der Pol,Sipke T. Visser,Maarten J. Postma,Mark H. Rozenbaum +6 more
TL;DR: The median drug price after patent expiration decreased by 41% after 4 years, which can be used to provide more reliable estimates on drug prices over its lifecycle and can be implemented in economic evaluations to inform the cost-effectiveness and long-term budget impact of new drugs.
Journal ArticleDOI
MSR141 Building Bridges: What Pandemic Preparedness Can Learn From Real-Option Value Analyses of Water Infrastructure in the Netherlands
TL;DR: In this article , the authors exemplify methods to apply real option value analysis for infectious disease prevention, by highlighting lessons learnt from Dutch wet infrastructure, which led to local analysts adopting real option (RO) value analyses to evaluate investments in potential projects.
Journal ArticleDOI
P53 The Early Lessons of COVID-19: The Need for a Broader Health-Economic Perspective
TL;DR: In this paper , the authors quantify the impact of the current COVID-19 pandemic on the Dutch government's fiscal position, simultaneously indicating the value of preventive vaccines from a payer perspective.